Niall O'Donnell
CIK 1780235 · last filed 2023-06-08
Niall O'Donnell is a corporate insider who has filed 16 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for MIRM, was dated Sep 6, 2023. Across all open-market trades the lifetime net is +$8.3M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $190.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$190.74M
3
16
$8.29M
Holdings By Company
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-09-06 | MIRM | Notice (144) | −51,000 | -$1.43M | EDGAR |
| 2023-06-08 | OnKure Therapeutics, Inc. (RPHM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-26 | SPRB | Grant (A) | — | $0 | EDGAR |
| 2023-05-16 | SPRB | Buy (P) | +630,400 | $2.00M | EDGAR |
| 2023-05-10 | OnKure Therapeutics, Inc. (RPHM) Delisted | Buy (P) | +125,000 | $1.00M | EDGAR |
| 2022-11-15 | MIRM | Sell (S) | −300,000 | -$5.96M | EDGAR |
| 2022-06-06 | MIRM | Grant (A) | — | $0 | EDGAR |
| 2022-06-03 | OnKure Therapeutics, Inc. (RPHM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-27 | SPRB | Grant (A) | — | $0 | EDGAR |
| 2021-06-08 | MIRM | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.